Early bird Tickets Available Now. Click Here.
This session will provide a detailed look at marketing considerations for growers and licensed producers including:
Moderator – Bridget Hoffer
This session will highlight aspects of the craft cannabis industry, specifically, in regards to what methods and process’ define a craft model, and how those aspects will not only define that products quality, but overall value as well. Matthew will discuss the importance of a quality driven market and talk about why it so important, not just for an overall healthy cannabis market, but particularly for those seeking cannabis for its therapeutic use.
Since the Canadian legalization of Cannabis in October 2018, the industry has seen significant growth. The Federal laws are heavily weighted toward licensing, production, and cultivation requirements, quality, and testing requirements, with minimal environmental guidance. Although the legal requirements from an environmental standpoint for producers have not changed significantly since legalization, municipalities have been forced to deal with many nuisance complaints from area residents regarding odours, noise, dust, and light from production and cultivation operations. Municipalities in Ontario have passed by-laws to restrict facilities because of these nuisance issues. By far, odours have been the biggest challenge. Rosanna DiLabio with Pinchin will review the aspects and impacts of Cannabis operations with a focus on “nuisance” emissions, how they can be managed and outline odour control technology currently available. Vicki Hilborn with the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) will outline how nuisance concerns are being managed in rural areas of Ontario, what a “Good Neighbour Policy” is and will provide highlights about the odour research currently being supported by OMAFRA. Finally, you will hear from Richard Butler of Willms and Shier Environmental Lawyers about how legal agricultural protections apply to growers and what producers need to know about their environmental liabilities both from a civil and regulatory perspective. An interactive discussion and Q&A session will follow the presentations.
Moderator – Rosanna DiLabio
This session will review the different forms of intellectual property that are available to protect innovations in the fast growing field of psychedelics. In particular, this session will provide a detailed look at patenting psychedelic inventions and answer several questions:
It seems like a no-brainer – when you use words like organic, regenerative, no-till to describe your growing techniques – it sounds sustainable. But is it? Join the experts to discuss ways to move LSO into a regenerative future.
Moderator – Dr. Av Singh
In the last two years, dozens of approvals for psychedelic-assisted therapies have been approved for use by patients under the care of psychologists, psychiatrists, clinical counsellors, social workers, general practitioners, and nurses. Specifically, psilocybin has been a molecule of interest that has been a focal point to these alternative treatments, with patient access that falls under a Section 56(1) exemption under Part J of the Food and Drugs Act. From a commercialization standpoint, what licence type is required to prepare a regulated compound such as psilocybin for patients and what specific activities can be performed? What are the site-specific requirements? What evidence do we have to show that controlled substances like psilocybin may follow a similar path towards medicinal use that cannabis has taken? What is the potential for business in psychedelic mushrooms within the applicable legislation and what aspects can be leveraged to further the rate of company success? All this and more will be covered in this informative session.
When building or expanding an indoor farm, multiple factors impact whether it’s more profitable to add tiers to existing cultivation rooms or increase footprint. In this session, we use data from real projects to first breakout the cost of building an indoor farm. Then, we use that model to illustrate the myriad of factors that building designers should consider when asking the question “should we add more tiers or increase footprint.” We leave sufficient time for the audience to ask question and share their thoughts.
Psychedelic substances have been around for millenia used by cultures across the globe as medicines and in ceremonies. Most were legal in North America as medicines or in medical research until the 1970’s – 1980’s until the racist and cultural control tactics of the War on Drugs pushed the use of these medicines underground. Now thanks to the persevering work of researchers, scientists, First Nations and therapists from all backgrounds we see these medicines returning to use for PTSD, depression, anxiety, eating disorders, addiction and more. Join Dr. Pamela Kryskow to review a survey of where we are at with these medicines in Canada.
The Grow Up Industry Awards Gala is a national annual event honouring cannabis professionals/companies and recognizing excellence in our industry. Join us as we induct Frenchy Cannoli in memoriam in to the Grower Hall of Fame along with 35 award winners. Ceremony will be held in the Main Theatre of the Scotiabank Convention Centre. Reception and After Party to be held in the hall outside of the theatre. General Theatre seating.
Reception: 4:30PM // Awards Ceremony: 5:00PM
Meet the Exhibitors Networking Party: 6:30PM (only available to VIP Industry Pass Holders and Exhibitors)
Host & Emcee – Ben Miner, Comedian
Recent Comments